Peak Performance Peptides
Has Peak Performance Peptides received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued Peak Performance Peptides a warning letter naming semaglutide and retatrutide, dated Aug 24, 2026, with the FDA subject line “Unapproved New Drugs/Misbranded.”
FDA records in this index name Peak Performance Peptides on Aug 24, 2026.
- Websites the letters name
- pppepz.com (see how each letter refers to them)
- Type named in FDA records
- Not stated
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide, Retatrutide
- Latest record
- Aug 24, 2026
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Aug 24, 2026 | Unapproved New Drugs/Misbranded | Semaglutide, Retatrutide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Aug 24, 2026: … Based on our review, “Bac water,” “GLP-3R” (retatrutide), “ Semaglutide ,” “SS-31,” “PT-141,” and “Tesamorelin” 1 are … of your website, “Bac water,” “GLP-3R” (retatrutide), “ Semaglutide ,” “SS-31,” “PT-141,” and “Tesamorelin” are drugs … models of cardiometabolic and metabolic research” Semaglutide On, e.g., the webpage … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- pppepz.com: FDA’s warning letter of Aug 24, 2026 is addressed to Peak Performance Peptides. It refers to the site in these words: “FDA Review Violations were identified and documented during a review of your website pppepz.com in July 2026.” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.